Berapa harga Ergomed plc (2EM)

Harga Ergomed plc (2EM) adalah $13.05

Apa kapitalisasi pasar Ergomed plc (2EM)

Kapitalisasi pasar Ergomed plc (2EM) adalah $695.07M

Riwayat Harga Ergomed plc (2EM)

Ergomed plc, alongside its affiliated entities, offers a comprehensive range of clinical trial services, encompassing planning, oversight, and execution, in addition to providing essential drug safety and medical information support. The company maintains an expansive global footprint, conducting operations throughout the United Kingdom, continental Europe, the Middle East, Africa, North America, Asia, and Australia. Its business is organized into two core divisions: Clinical Research Services and Pharmacovigilance. Ergomed assists pharmaceutical, biotechnology, and generic drug manufacturers by managing clinical development programs, facilitating post-market approval strategies, and delivering robust pharmacovigilance solutions. Their expertise is concentrated in several therapeutic domains, including oncology, haematology, allergy, respiratory, and neurology/CNS, with a notable specialization in the development of orphan drugs. Furthermore, they extend support services to clinical trial sites. Established in 1997, the organization originally traded as Ergomed Clinical Research Limited before rebranding as Ergomed plc in June 2014. Its corporate headquarters are situated in Guildford, United Kingdom.

Tahun	Performa
2023	-19.23%
2022	-14.51%
2021	42.48%
2020	165.99%
2019	168.03%
2018	-27.38%
2017	35.65%
2016	-30.33%
2015	0.00%

Tahun

Performa

2023

-19.23%

2022

-14.51%

2021

42.48%

2020

165.99%

2019

168.03%

2018

-27.38%

2017

35.65%

2016

-30.33%

2015

0.00%

Perusahaan	Harga saham	Perubahan 1th%	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	$542.09	38.63%	US
Argenx SE ARGX.US	$1.03K	44.13%	NL
CSL Limited CSL.AX	$121.53	-12.70%	AU
Moderna, Inc. MRNA.US	$138.18	473.58%	US
Lonza Group AG LONN.SW	$759.27	7.20%	CH

Perusahaan

Harga saham

Perubahan 1th%

Negara